Cargando…
Application and Prospect of CRISPR/Cas9 Technology in Reversing Drug Resistance of Non-Small Cell Lung Cancer
Cancer drug resistance has always been a major factor affecting the treatment of non-small cell lung cancer, which reduces the quality of life of patients. The clustered regularly interspaced short palindromic repeats/CRISPR associated protein 9 (CRISPR/Cas9) technology, as an efficient and convenie...
Autores principales: | Huang, Lu, Liao, Zhi, Liu, Zhixi, Chen, Yan, Huang, Tingwenli, Xiao, Hongtao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9127258/ https://www.ncbi.nlm.nih.gov/pubmed/35620280 http://dx.doi.org/10.3389/fphar.2022.900825 |
Ejemplares similares
-
Research Progress of Chloroquine and Hydroxychloroquine on the COVID-19 and Their Potential Risks in Clinic Use
por: Chen, Yan, et al.
Publicado: (2020) -
Knockout of ABC transporters by CRISPR/Cas9 contributes to reliable and accurate transporter substrate identification for drug discovery
por: Feng, Dongyan, et al.
Publicado: (2022) -
Combining Zebrafish and CRISPR/Cas9: Toward a More Efficient Drug Discovery Pipeline
por: Cornet, Carles, et al.
Publicado: (2018) -
Canthin-6-One Accelerates Alpha-Synuclein Degradation by Enhancing UPS Activity: Drug Target Identification by CRISPR-Cas9 Whole Genome-Wide Screening Technology
por: Yuan, Ning-Ning, et al.
Publicado: (2019) -
The Current State and Future of CRISPR-Cas9 gRNA Design Tools
por: Wilson, Laurence O. W., et al.
Publicado: (2018)